Teva Pharma Wins FDA Approval For Generic Accupril Tablets - Quick Facts
Monday, August 27, 2007; Posted: 11:12 AM
(RTTNews) - Teva Pharmaceutical Industries Ltd. (
TEVA |
charts |
news |
PowerRating) on Monday revealed the U.S. Food and Drug Administration's final approval for the company's Abbreviated New Drug Application to market its generic version of Pfizer's hypertension treatment Accupril or Quinapril Hydrochloride Tablets, 5 mg, 10 mg, 20 mg and 40 mg. The company said that the shipment of the product would begin shortly.
For comments and feedback: contact editorial@rttnews.com Copyright(c) 2007 RealTimeTraders.com, Inc. All Rights Reserved
Morning Coffee with TradingMarkets -- Free Newsletter
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
Email Article Link
Close X
